Joel Becker, Chief Executive Officer and Director of NeuroPace Inc., filed a Form 4 on November 17, 2026, disclosing the open-market purchase of 11,891 shares of NeuroPace common stock on that same date.
Key Highlights
- Reporting person: Joel Becker, identified in the filing as Chief Executive Officer and Director of NeuroPace Inc. (NASDAQ:NPCE).
- Shares acquired: 11,891 shares of common stock acquired on November 17, 2026, with transaction code "P" (purchase).
- Weighted average price: $8.3503 per share, with individual transaction prices ranging from $7.92 to $8.50, inclusive, according to the filing.
- Resulting ownership: Following the transaction, Becker directly holds 149,891 shares of NeuroPace common stock.
- Rule 10b-18 compliance: The filing states purchases were made in compliance with SEC Rule 10b-18 safe harbor restrictions for manner, timing, price, and volume, and also complied with broker-dealer and issuer pre-clearance procedures.
Joel Becker's November 2026 Common Stock Purchase at NeuroPace
According to the Form 4 filed with the SEC, Joel Becker, who serves as both Chief Executive Officer and Director of NeuroPace Inc., acquired 11,891 shares of the company's common stock on November 17, 2026. The transaction was recorded under transaction code "P," indicating an open-market purchase. The filing reports a weighted average price of $8.3503 per share across multiple transactions.
The filing discloses that the shares were purchased in multiple transactions at prices ranging from $7.92 to $8.50, inclusive. The filing notes that Becker "undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4." Following the reported transaction, the filing states that Becker directly beneficially owns 149,891 shares of NeuroPace common stock.
The filing further states that the purchases were made in compliance with SEC Rule 10b-18 safe harbor restrictions governing the manner, timing, price, and volume of purchases, and that the transactions also complied with broker-dealer and issuer pre-clearance procedures. The Form 4 was signed by Leah Akin as Attorney-in-Fact on November 17, 2026, the same date as the transaction.
What Was Disclosed
NeuroPace CEO Joel Becker filed a Form 4 reporting the purchase of 11,891 shares of common stock at a weighted average price of $8.3503 on November 17, 2026, bringing his direct beneficial ownership to 149,891 shares.




Please wait processing your request...